Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 4,336 shares at $8.01 ($35K) on 2023-07-05, disclosed to the SEC on 2023-07-07.
Scheduled sale ($35k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |